Jean Gariépy
Direttore Tecnico/Scientifico/R&S presso Ontario Cancer Institute
Posizioni attive di Jean Gariépy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Toronto | Corporate Officer/Principal | - | - |
| Ontario Cancer Institute | Direttore Tecnico/Scientifico/R&S | 02/09/2009 | - |
Storia della carriera di Jean Gariépy
Precedenti posizioni note di Jean Gariépy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Princess Margaret Hospital Foundation | Corporate Officer/Principal | - | - |
| MOLECULAR TEMPLATES, INC. | Fondatore | 01/01/2000 | - |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | - |
| Fondatore | 02/09/2009 | - |
Formazione di Jean Gariépy
| University of Alberta | Doctorate Degree |
Statistiche
Distribuzione geografica
| Canada | 5 |
| Stati Uniti | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
| Princess Margaret Hospital Foundation | |
| Ontario Cancer Institute |
- Borsa valori
- Insiders
- Jean Gariépy
- Esperienza
